Market Cap: $8.2M
QL
Quoin Pharmaceuticals, Ltd.
QNRX
NASDAQ (NASDAQ Capital Market)USD
Market Cap: $8.2M
GenScript Biotech's Annual Forum: A Catalyst for Innovation in Biotechnology GenScript Biotech Corporation is set to host its 5th Annual Biotech Global Forum on January 14, 2026, at the San Francisco…
Specific Biologics Appoints Dr. Richard Glickman to Board, Aiming at Growth in Genome Editing Specific Biologics Inc., a precision in vivo genome editing company, enhances its leadership with the appo…
Quoin Pharmaceuticals Advances in Rare Disease Therapeutics Quoin Pharmaceuticals is making significant strides in the development of therapeutics for rare diseases, particularly focusing on the treat…
Quoin Pharmaceuticals Advances in Rare Disease Treatments Quoin Pharmaceuticals, a biopharmaceutical company focused on developing innovative therapies for rare diseases, announces significant progres…
It appears that there was a misunderstanding, as I did not receive any specific content to summarize regarding Quoin Pharmaceuticals or any related developments. If you could provide the text or infor…
### Quoin Pharmaceuticals: Advancements in Immuno-Oncology Therapeutics Quoin Pharmaceuticals is making significant strides in the field of immuno-oncology, where the focus lies on leveraging the body…
Quoin Pharmaceuticals: Advancing Immuno-Oncology Solutions Amidst Evolving Market Dynamics Quoin Pharmaceuticals is at the forefront of innovation in the immuno-oncology sector, focusing on harnessing…
Quoin Pharmaceuticals: Pioneering Immuno-Oncology Solutions Quoin Pharmaceuticals is at the forefront of innovation in the immuno-oncology sector, focusing on developing novel therapeutic solutions to…
Quoin Pharmaceuticals Navigates Industry Challenges with Promising Developments Quoin Pharmaceuticals operates in a dynamic landscape where the intersection of pharmaceuticals and technology continues…
Quoin Pharmaceuticals: Focus on Innovation in the Biopharmaceutical Landscape Quoin Pharmaceuticals positions itself strategically within the biopharmaceutical industry, where innovation and the devel…
Actinium Pharmaceuticals Advances Targeted Therapies for Cancer Treatment Actinium Pharmaceuticals, Inc., a prominent player in the field of targeted radiotherapies, is making significant strides in t…
Actinium Pharmaceuticals Advances Targeted Radiotherapy Solutions for Cancer Treatment Actinium Pharmaceuticals, Inc. is making significant strides in the development of targeted radiotherapies that a…
Advancements in Targeted Radiotherapy: Actinium Pharmaceuticals' Innovative Approach Actinium Pharmaceuticals, Inc. is making significant strides in the field of targeted radiotherapies, focusing on i…
Innovative Engagement: INOVIO's Commitment to Investor Relations INOVIO Pharmaceuticals, a key player in the biotechnology space, is set to showcase its advancements in DNA medicines at the upcoming S…
Strategic AI Partnership Set to Transform Swiss Biotechnology Landscape Swiss Rockets AG, a Basel-based biotechnology incubator and accelerator, announces a strategic partnership with Squirro AG, a le…
Swiss Rockets AG Partners with Squirro AG to Revolutionize AI in Biotechnology Swiss Rockets AG, a biotechnology incubator and accelerator based in Basel, has announced a strategic partnership with Sq…
Caravel Bio Secures $7.8 Million Grant to Transform Protein Engineering Landscape Caravel Bio, an innovative biotechnology firm based in Portland, Oregon, has recently been awarded a $7.8 million gran…
Sherak Revolutionizes Skincare for Women Over 40 with New Product Line Sherak, a forward-thinking biotechnology-driven luxury skincare company, recently unveils its Skin Renewal Chemistry System, aime…
Sherak Launches Revolutionary Skincare System for Midlife Women Sherak, a biotechnology-driven luxury skincare company founded by Jennifer Sherak, has debuted its innovative Skin Renewal Chemistry Sys…
I apologize, but it seems that there is no content provided for summarization. If you could share the relevant text regarding Quoin Pharmaceuticals, I would be happy to help you create a summary based…
Quoin Pharmaceuticals Secures $104.5 Million Financing to Advance Pipeline Development Quoin Pharmaceuticals Ltd. announces a transformative financing deal that is set to significantly bolster its ope…
Quoin Pharmaceuticals: Riding the Wave of Biotech Momentum Quoin Pharmaceuticals finds itself at the heart of a burgeoning trend within the biotechnology sector, where a select group of companies is e…
Rising Momentum in Biotechnology: A Spotlight on Quoin Pharmaceuticals In the rapidly evolving biotechnology landscape, Quoin Pharmaceuticals finds itself amidst a wave of heightened interest driven b…
Matica Biotechnology's Strategic Expansion in Cell and Gene Therapies Matica Biotechnology, Inc. announces significant growth in its operations within the cell and gene therapy (CGT) sector. The compa…
Matica Biotechnology's Expansion in Gene Therapy Manufacturing Reflects Industry Demand Matica Biotechnology, Inc., a prominent player in the Contract Development and Manufacturing Organization (CDMO)…